NR1I3 and hepatocellular carcinoma: However, the clinical efficacy and future potential use of lncRNA F11‐AS1/miR‐211‐5p/NR1I3 axis in treatment of HBV‐related HCC warrant further studies to improve the overall outcomes of HCC patients.